跳至主要内容
临床试验/CTRI/2025/04/084408
CTRI/2025/04/084408尚未招募4 期

To study the role of individualized homoeopathic medicine in cases of acute gastroenteritis with the help of repertory of homoeopathic materia medica by Dr. J. T. Kent

DR DIPIKABEN CHIMANLAL PARMAR1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年4月18日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Vesikari Clinical Severity Score

研究概览

简要总结

This study is randomized, participant blinded, single center trial to study the role of the individualized homoeopathic medicine in cases of acute gastroenteritis. In this study participants will be recruited as mentioned in inclusion and exclusion criteria. Case taking will be done according to the guidelines mentioned by Hahnemann in Organon of Medicine. After proper analysis and evaluation of symptoms of the case, totality of symptoms will be formed. Medicine will be selected after repertorization with Kent repertory. As an assessment tool Vesikari Clinical Severity Scoring System will be used. Remedy will be prescribed in various potencies as per the requirement. Follow up of each case will be taken at the interval of 3,5,7 days or as per the requirement. Primary and secondary outcomes will be measured as mentioned earlier.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant Blinded

入排标准

年龄范围
10.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Cases with pre-diagnosed or with clinical presentation of Acute Gastroenteritis.

排除标准

  • Cases with irregular follow-up Cases with severe pathological disease Cases with Vesikari Clinical Severity Scoring more than or equal to 11 Cases with pregnancy.

结局指标

主要结局

Vesikari Clinical Severity Score

时间窗: At the beginning and at the end of the treatment, at the interval of 3,5,7 days or as per requirement

次要结局

  • Cured -Sensation of well being mentally and physically with disappearance of all symptoms of acute gastroenteritis with score of vesikari clinical scoring system reduced to 0-1.(Improved - Decrease in intensity and frequency of presenting complaints with feeling of well being and score of Vesikari Clinical Severity Score reduced but not reached to 0-1.)

研究者

发起方
DR DIPIKABEN CHIMANLAL PARMAR
申办方类型
Other [The principal investigator]

研究点 (1)

Loading locations...

相似试验